This case report presents a series of three patients diagnosed with neuroendocrine tumors (NETs), each illustrating different applications of theranostics to guide their clinical care.
**Case 1:** A patient with metastatic insulinoma presenting with refractory hypoglycemia despite multiple interventions.
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
